Transcription of New pharmaceutical excipients in solid dosage …
{{id}} {{{paragraph}}}
Review Article [Patel et al., 2(8): Aug., 2011] ISSN: 0976-7126 Int. J. of Pharm. & Life Sci. (IJPLS), Vol. 2, Issue 8: Aug.: 2011, 1006-1019 1006 INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES New pharmaceutical excipients in solid dosage forms A review Hardik Patel *, Viral Shah and Umesh Upadhyay Department of Pharmaceutics, Sigma institute of Pharmacy, Baroda, (Gujarat) - India Abstract The objective of a medicinal formulation development project is to deliver drug to the patient in the required amount, at the required rate, consistently within a batch, from batch to batch, and over the product s shelf life. To produce a drug substance in a final dosage form requires pharmaceutical ingredients. In selecting excipients for pharmaceutical ; dosage forms and drug products the development pharmacist should be certain that standards exist and are available to assure the consistent quality and functioning of the excipient from lot to lot.
Review Article [Patel et al. , 2(8): Aug., 2011] ISSN: 0976-7126 Int. J. of Pharm. & Life Sci. (IJPLS), Vol. 2, Issue 8: Aug: 2011, 1006-1019 1007 only …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
WAIVE IN VIVO BIOEQUIVALENCE, Waive in vivo bioequivalence requirements, Solid, Dosage, Dosage Form Design: Pharmaceutical and, Pharmaceutical dosage, DEVELOPMENT OF PAEDIATRIC MEDICINES:, COMMITTEE FOR MEDICINAL PRODUCTS FOR, Excipients, Article, Pharmaceutical, Polymers used for Fast Disintegrating Oral Films